OmanDocSign in

Curriculum · Hematology

Polycythaemia vera

What it is

Polycythemia vera is a myeloproliferative neoplasm: the marrow makes red cells autonomously, so the RBC rises independent of EPO. It is often associated with a JAK2 mutation, and it can raise the WBCs and the platelets as well, not the red cells alone. The symptoms come from hyperviscosity and from cell turnover.

Causes and risk

Polycythemia vera is the primary cause of erythrocytosis, and the whole point of the tests is to set it against the rest.

Secondary and physiologic, from poor tissue oxygenation or hypoxia:

Inappropriate production of erythropoietin:

Relative polycythemia, where the plasma volume falls while the RBC mass does not rise, comes from dehydration and burns.

How it presents

The symptoms are secondary to a high red cell mass and hyperviscosity: headache, dyspnea, dizziness, tinnitus, visual disturbances, hypertensive symptoms, numbness and tingling, angina and congestive heart failure.

Two features stand out:

Thrombosis, venous or arterial, or bleeding, follows the increased blood viscosity and the increased platelet count or activity: DVT, PE, Budd-Chiari from hepatic vein thrombosis, portal vein thrombosis, thrombophlebitis, and an increased incidence of stroke and MI.

On examination: splenomegaly, in 70%, with or without hepatomegaly, in 40%; facial plethora or a ruddy complexion, in 70%; and gout.